They are all seated on one floor, headphones plugged in, talking on multiple phones—not telemarketers but doctors teleconsulting in hushed voices. The centre is sectioned with dividers at shoulder height, creating small cubicles—made of mud and covered in traditionally painted murals. The walls are tall and unusual—they’re made of bamboo.

Everything about this office is familiar and yet nothing is. We’re in India’s first and largest teleconsultation centre on ayurveda.

Each day, over 8,000 people call the 250 doctors seated across centres. The one we’re in is located in a satellite town in NCR. Thursday mornings are a busy time here. Busier even than at Practo, India’s largest doctor network, which hosts 150 calls from patients every day.

Tele-consultation on ayurveda

Jiva has a tie-up for their ayurveda doctor-on-call service with telecom companies - Airtel, Vodafone and Idea. 2000 people call Jiva via this feature in a day

All of this is the product of 55-year-old ayurvedic doctor Partap Chauhan. A man with a simple vision—make ancient Indian medicine accessible again. Chauhan founded Jiva Ayurveda in 1992—a single ayurvedic clinic in a village not very far from this teleconsultation centre. At the time, he was consulting patients over the weekends in Vrindavan, Uttar Pradesh.

Over the next 15 years, expats would invite him to Europe and the US to share his knowledge of ayurveda. Aided by the telecommunication revolution, he first set up a website to share this knowledge and consult in 1995. This eventually expanded to the teleconsultation centre we’re standing in.

The idea was to increase accessibility by integrating ayurveda with modern technology. To research and make its practice consistent and reliable. Chauhan achieved that last year. In a first-of-its-kind big data analysis, Jiva proved that Chauhan’s protocols for diagnosis and prescribing ayurvedic medicines were effective for over 75% of 353,000 patients, to varying degrees. Who were these patients? Jiva’s teleconsultation patients.

“That is remarkable. I can also say that ayurveda does not work for some people. But we know in modern medicine too that not all medicine works on everyone,” says Samir Brahmachari, former director general of the Council of Scientific & Industrial Research (CSIR). Brahmachari was also the former secretary of the Department of Scientific and Industrial Research (DSIR).

Brahmachari was the one who actually analysed the electronic health records of Jiva’s patients. He co-wrote and published his analysis last year in the journal Progress in Preventive Medicine. This is noteworthy because most modern drugs are developed outside India by Big Pharma, and Indian patients hardly get the desired representation in early clinical studies. In contrast, Jiva has data on a wide swathe of the Indian population.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?

MOST POPULAR

Annual Subscription

12-month access to 200+ stories, archive of 800+ stories from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 2,750

Subscribe
 

Quarterly Subscription

3-month access to 60+ new stories with 3-months worth of archives from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 1,750

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

Rs. 500

Subscribe
MOST POPULAR

Annual Subscription

12-month access to 150+ stories from Southeast Asia.

$ 120

Subscribe
 

Quarterly Subscription

3-month access to 35+ stories from Southeast Asia.

$ 50

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

$ 20

Subscribe

Questions?

What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

For subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.